Pharmacokinetics of Levofloxacin, a New Fluoroquinolone Agents, After Instillation of 0.5% 14c-Levofloxacin Ophthalmic Solution to Pigmented Rats.

Drug Metabolism and Pharmacokinetics
doi 10.2133/dmpk.12.281
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society for the Study of Xenobiotics

Related search

Post-Marketing Surveillance of Levofloxacin 0.5% Ophthalmic Solution for External Ocular Infections

Drugs in R and D
Pharmacology
2012English

Erratum To: Levofloxacin: A Review of Its Antibacterial Activity, Pharmacokinetics and Therapeutic Efficacy

Drugs
Pharmacology
1994English

Tissue Pharmacokinetics of Levofloxacin in Human Soft Tissue Infections

British Journal of Clinical Pharmacology
Pharmacology
2004English

Pharmacokinetics of Levofloxacin Following Intravenous and Subcutaneous Administration in Sheep

Asian Journal of Animal and Veterinary Advances
Animal ScienceZoologyVeterinary
2012English

Levofloxacin Induced Dyslipidemia in Male Albino Rats

Asian Journal of Pharmacy and Pharmacology
2018English

Pharmacodynamics of Levofloxacin

JAMA - Journal of the American Medical Association
Medicine
1998English

Pharmacokinetics of Levofloxacin in Children Treated for Drug-Resistant TB Exposure

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Ocular Pharmacokinetics of Bimatoprost Formulated in DuraSite Compared to Bimatoprost 0.03% Ophthalmic Solution in Pigmented Rabbit Eyes

Clinical Ophthalmology
Ophthalmology
2013English

Pharmacokinetics of Levofloxacin in Multidrug- And Extensively Drug-Resistant Tuberculosis Patients

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy